Comparison of the efficacy of sucroferric oxyhydroxide and lanthanum carbonate in the hyperphosphatemia of maintainable Hemodialysis. [PDF]
Li M, Kang Y, Zhang C, Ni X.
europepmc +1 more source
Comparison of the effects of lanthanum carbonate and calcium carbonate on the progression of cardiac valvular calcification after initiation of hemodialysis. [PDF]
Watanabe K +4 more
europepmc +1 more source
Proton pump inhibitors may hinder hypophosphatemic effect of lanthanum carbonate, but not of ferric citrate hydrate or sucroferric oxyhydroxide, in hemodialysis patients. [PDF]
Minakuchi H +8 more
europepmc +1 more source
A Targeted Release Capsule of Lanthanum Carbonate: a New Efficient Cheap Treatment for Primary Hyperoxalurias. [PDF]
De Broe ME +8 more
europepmc +1 more source
Distribution of lanthanum carbonate in the gastric mucosa confirmed by electron microscopy with a magnified endoscopy: a case report and literature review. [PDF]
Yamada T +7 more
europepmc +1 more source
Corrigendum to "A Targeted Release Capsule of Lanthanum Carbonate: A New Efficient Cheap Treatment for Primary Hyperoxalurias" [Volume 10, Issue 2, February 2025, Pages 503-515]. [PDF]
De Broe ME +8 more
europepmc +1 more source
Effect of Lanthanum Carbonate on Serum Phosphate, Oxidative Stress, and Vascular Dysfunction in CKD: A Mechanistic Randomized Controlled Trial. [PDF]
Jovanovich A +9 more
europepmc +1 more source
Therapeutic effectiveness and safety profile of lanthanum carbonate in conjunction with calcium carbonate for managing hyperphosphatemia in hemodialysis patients: a meta-analysis of randomized controlled trials. [PDF]
Fang H, Chen C.
europepmc +1 more source
Successful Treatment of Tumoral Calcinosis by Lanthanum Carbonate. [PDF]
Hsiao CC, Lee CC, Chen KH.
europepmc +1 more source

